GlassScriptPhysician profile
Pamela D Murphy
NPI 1841386273
$7,084.11
in general payments reported to CMS, 2019-2025
45 companies · $1,259 in 2025
The $1,259 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $895 · 2020: $943 · 2021: $1,050 · 2022: $968 · 2023: $914 · 2024: $1,054 · 2025: $1,259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,227.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,191.46 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $780.13 | 2021-2025 | |
| Novo Nordisk INC | $768.83 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $389.56 | 2019-2025 | |
| Lilly USA, LLC | $389.16 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Amgen INC. | $360.41 | 2019-2025 | Evenity, Prolia |
| Otsuka America Pharmaceutical, INC. | $311.21 | 2020-2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $280.09 | 2019-2025 | Austedo Xr, Austedo |
| Novartis Pharmaceuticals Corporation | $276.62 | 2019-2025 | |
| Allergan, INC. | $245.25 | 2019-2020 | |
| Astellas Pharma US INC | $226.98 | 2019-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.57 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Merck Sharp & Dohme LLC | $169.15 | 2019-2023 | Belsomra |
| Phathom Pharmaceuticals, INC. | $137.88 | 2024 | Voquezna |
| Abbott Laboratories | $121.66 | 2022-2023 | Freestyle Libre 2 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.